SELLAS Life Sciences Group (SLS) Stock
$11.34
−4.55% Close Oct 15
Open interactive chartSLS stock price today
- Last close
- $11.34
- Day range
- $11.15 to $11.92
- 52-week range
- $1.39 to $15.88
- From 52-week high
- −28.6%
- Average volume (50 days)
- 6.3M
- 1 week
- +0.7%
- 1 month
- −2.7%
- 3 months
- −14.0%
- Year to date
- +200.8%
- 1 year
- +453.2%
- 3 years
- +698.6%
- 5 years
- +30.2%
Is SLS stock in an uptrend?
Yes, SLS stock is in an uptrend: it does not meet the Minervini Trend Template criteria and both Daily Pivot Breakout momentum filters are active. Price is above its 200-day moving average.
- Daily Pivot momentum filters
- 2 of 2 active
- 100-day ROC
- +45.8% filter at 40%: active
- 100-day EMA slope
- +130.6% filter at 25%: active
- Trend state
- Uptrend
- Minervini Trend Template
- Not met on the latest scan
- 50-day average
- Below
- 150-day average
- Above
- 200-day average
- Above
- 200-day slope (1 month)
- +13.91%
- ATR (14) % of price
- 6.08%
Momentum filters from the Daily Pivot Breakout indicator: 100-day rate of change and 100-day EMA slope, each against its minimum.
SLS support and resistance levels
| Level | Price | From close |
|---|---|---|
| Daily Pivot resistance (pivot high) | $12.53 | +10.5% |
| 50-day SMA | $12.45 | +9.8% |
| 21-day EMA | $11.83 | +4.3% |
| 9-day EMA | $11.71 | +3.2% |
| Latest Daily Pivot low | $10.78 | −4.9% |
| 30-week SMA | $9.75 | −14.0% |
| 150-day SMA | $9.48 | −16.4% |
| 200-day SMA | $8.19 | −27.8% |
Levels above the close act as resistance, levels below as support. Last close $11.34.
SLS breakout and scanner signals
| Scanner | Last signal (free view, 5 sessions late) | Past year |
|---|---|---|
| Daily Pivot Breakout | Jun 25, 2026 | 2 |
| Minervini Trend Template | Sep 10, 2026 | 24 |
| Episodic Pivot | None in the last year | 0 |
| Ichimoku TK cross | Sep 11, 2026 (bearish) | 3 |
| 9/21 EMA cross | Sep 14, 2026 (bearish) | 3 |
SLS seasonality by month
- Jan−0.6%50% up
- Feb+0.7%44% up
- Mar+0.1%33% up
- Apr+1.7%37% up
- May+15.9%68% up
- Jun−10.9%32% up
- Jul−5.5%32% up
- Aug−4.8%37% up
- Sep+0.6%37% up
- Oct+3.7%39% up
- Nov−1.5%33% up
- Dec+5.1%28% up
Average monthly return over 18+ years of stored daily closes, and the share of years each month closed higher.
SLS bull and bear case
What looks strong
- Both Daily Pivot momentum filters are active (100-day ROC 45.8%, 100-day EMA slope 130.6%).
- The 50, 150 and 200-day averages are stacked in uptrend order.
- Price is above a rising 200-day moving average.
What looks weak
- Does not meet the Minervini Trend Template on the latest scan.
- Price is below the 50-day moving average.
Drawn only from the data on this page. Not a recommendation.
SLS news and SEC filings, last 30 days
No SEC filings in the last 30 days.
SLS valuation and fundamentals
- Gross margin
- –
- Operating margin
- –
- Profit margin
- –
- Return on equity
- –
- Revenue growth (quarter, y/y)
- –
Who owns SLS?
- Held by insiders
- –
- Held by institutions
- –
- Short interest (% of shares)
- –
What does SELLAS Life Sciences Group, Inc. do?
- CEO
- Dr. Angelos M. Stergiou M.D., ScD h.c.
- Employees
- 15
- Headquarters
- New York, NY, United States
- Website
- sellaslifesciences.com